Critical Care Explorations (Feb 2024)

Epidemiology, Clinical Characteristics, and Outcomes of 4546 Adult Admissions to High-Dependency and ICUs in Kenya: A Multicenter Registry-Based Observational Study

  • Carolyne Njoki, MD,
  • Nabukwangwa Simiyu, MD,
  • Ronnie Kaddu, MD,
  • Wambui Mwangi, MD,
  • Demet Sulemanji, MD,
  • Peter Oduor, MD,
  • Dilanthi Gamage Dona, MS,
  • Dorothy Otieno, MS,
  • Teddy Thaddeus Abonyo, BSN,
  • Patricia Wangeci,
  • Thomas Kabanya, Nurse,
  • Selina Mutuku,
  • Annastacia Kioko, Nurse,
  • Joy Muthoni,
  • Peter Mburu Kamau, Nurse,
  • Abigail Beane, PhD,
  • Rashan Haniffa, PhD,
  • Arjen Dondorp, Prof, PhD,
  • David Misango, MD,
  • Luigi Pisani, PhD,
  • Wangari Waweru-Siika, MD

DOI
https://doi.org/10.1097/CCE.0000000000001036
Journal volume & issue
Vol. 6, no. 2
p. e1036

Abstract

Read online

OBJECTIVES:. To describe clinical, management, and outcome features of critically ill patients admitted to ICUs and high-dependency units (HDUs) in Kenya. DESIGN:. Prospective registry-based observational study. SETTING:. Three HDUs and eight ICUs in Kenya. PATIENTS:. Consecutive adult patients admitted between January 2021 and June 2022. INTERVENTIONS:. None. MEASUREMENTS AND MAIN RESULTS:. Data were entered in a cloud-based platform using a common data model. Study endpoints included case-mix variables, management features, and patient-centered outcomes. Patients with COVID-19 were reported separately. Of the 3892 of 4546 patients without COVID-19, 2445 patients (62.8%) were from HDUs, and 1447 patients (37.2%) were from ICUs. Patients had a median age of 53 years (interquartile range [IQR] 38–68), with HDU patients being older but with a lower severity (Acute Physiology and Chronic Health Evaluation II 6 [3–9] in HDUs vs. 12 [7–17] in ICUs; p < 0.001). One in four patients was postoperative with 604 (63.4%) receiving emergency surgery. Readmission rate was 4.8%. Hypertension and diabetes were prevalent comorbidities, with a 4.0% HIV/AIDS rate. Invasive mechanical ventilation was applied in 3.4% in HDUs versus 47.6% in ICUs (p < 0.001), with a duration of 7 days (IQR 3–21). There was a similar use of renal replacement therapy (4.0% vs. 4.7%; p < 0.001). Vasopressor use was infrequent while half of patients received antibiotics. Average length of stay was 2 days (IQR 1–5). Crude HDU mortality rate was 6.5% in HDUs versus 30.5% in the ICUs (p < 0.001). Of the 654 COVID-19 admissions, most were admitted in ICUs (72.3%) with a 33.2% mortality. CONCLUSIONS:. We provide the first multicenter observational cohort study from an African ICU National Registry. Distinct management features and outcomes characterize HDU from ICU patients.